Early appropriate diagnostics and treatment of MDR Gram-negative infections

M Bassetti, SS Kanj, P Kiratisin… - JAC-Antimicrobial …, 2022 - academic.oup.com
The term difficult-to-treat resistance has been recently coined to identify Gram-negative
bacteria exhibiting resistance to all fluoroquinolones and all β-lactam categories, including …

In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of …

P Sreenivasan, B Sharma, S Kaur, S Rana… - The Journal of …, 2022 - nature.com
Resistance in Gram-negative organisms has become one of the leading threats in recent
years. Of the different mechanisms described in the literature, resistance due to beta …

Nosocomial outbreak of monoclonal VIM carbapenemase-producing Enterobacter cloacae complex in an intensive care unit during the COVID-19 pandemic: an …

C Mullié, D Lemonnier, CC Adjidé, J Maizel… - Journal of Hospital …, 2022 - Elsevier
Background An outbreak of VIM carbapenemase-expressing Enterobacter cloacae complex
occurred between March and October 2020 in an intensive care unit (ICU) of a tertiary care …

[HTML][HTML] Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections

SY Park, YJ Baek, JH Kim, H Seong… - Infection & …, 2024 - pmc.ncbi.nlm.nih.gov
This guideline aims to promote the prudent use of antibacterial agents for managing
carbapenem-resistant Enterobacterales (CRE) infections in clinical practice in Korea. The …

Performance of disk diffusion method for aztreonam in combination with avibactam against Enterobacteriales

D Yin, P Song, L Jiang, J Xu, F Hu - Journal of Antimicrobial …, 2024 - academic.oup.com
Objectives To evaluate the performance of an in-house developed disk diffusion method for
aztreonam in combination with avibactam against Enterobacteriales. Methods The in vitro …